Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and effectiveness of extended release methylphenidate
(XR-MPH) in treating attention deficit hyperactivity disorder (ADHD) in children with both
ADHD and epilepsy.
Phase:
Phase 4
Details
Lead Sponsor:
Boston Children's Hospital Boston Children’s Hospital